Executive, Activities of Daily Living, and Cholinergic Functions in Parkinson's Disease
NCT ID: NCT00737217
Last Updated: 2013-06-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
74 participants
OBSERVATIONAL
2006-03-31
2009-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Memory Training in Parkinson Disease
NCT03582670
Striatal and Extra-striatal Mechanisms of Falling in Parkinson's Disease
NCT00736671
PET Study of Non-Motor Symptoms of Parkinson Disease
NCT01565473
Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol
NCT02952391
Rehabilitation of Everyday Memory Impairment in Parkinson Disease: A Pilot Study
NCT01469741
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Parkinson's disease
Behavioral assessment/questionnaire
Complete behavioral assessment/questionnaire
Normal Controls
Behavioral assessment/questionnaire
Complete behavioral assessment/questionnaire
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Behavioral assessment/questionnaire
Complete behavioral assessment/questionnaire
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* PD. Patients with who meet the UKPDSBRC criteria for PD with a MMSE of \>25 (n=28; age 50-85 years; M/F). Hoehn and Yahr stages I-III.
* Normal control subjects (n=16) (age 50-85 years; M/F).
* No current or past history of neurologic or psychiatric illness.
Exclusion Criteria
* Current or past history of neurologic or psychiatric illness.
50 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Michael J. Fox Foundation for Parkinson's Research
OTHER
University of Michigan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nicolaas Bohnen, MD, PhD
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Michigan Functional, Cognitive and Mobility Laboratory
Ann Arbor, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2005-0464
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.